Insider Trading Activity For Biostage, Inc. (NASDAQ:BSTG)
Saverio Lafrancesca , Insider of Biostage, Inc. (NASDAQ:BSTG) reportedly Bought 100,000 shares of the company’s stock at an average price of 0.37 for a total transaction amount of $37,000.00 SEC Form
Insider Trading History For Biostage, Inc. (NASDAQ:BSTG)
On 2/13/2015 Thomas Mcnaughton, CFO, bought 14,000 with an average share price of $2.67 per share and the total transaction amounting to $37,380.00.View SEC Filing
On 2/18/2015 David Green, CEO, bought 50,000 with an average share price of $1.75 per share and the total transaction amounting to $87,500.00.View SEC Filing
On 5/29/2015 Thomas Mcnaughton, CEO, bought 5,000 with an average share price of $1.91 per share and the total transaction amounting to $9,550.00.View SEC Filing
On 6/1/2015 Thomas Mcnaughton, CEO, bought 3,000 with an average share price of $1.74 per share and the total transaction amounting to $5,220.00.View SEC Filing
On 6/1/2015 John F Kennedy, Director, bought 10,000 with an average share price of $1.67 per share and the total transaction amounting to $16,700.00.View SEC Filing
On 6/2/2015 Thomas Mcnaughton, CEO, bought 8,000 with an average share price of $1.80 per share and the total transaction amounting to $14,400.00.View SEC Filing
On 6/2/2015 David Green, Director, bought 26,600 with an average share price of $1.81 per share and the total transaction amounting to $48,146.00.View SEC Filing
Analyst Ratings For Biostage, Inc. (NASDAQ:BSTG)
These are 1 Hold Rating .
The current consensus rating for Biostage, Inc. (NASDAQ:BSTG) is Hold (Score: 2.00) with a consensus target price of $3.00 , a potential (849.67% upside)
Analyst Ratings History For Biostage, Inc. (NASDAQ:BSTG)
- On 8/14/2017 Maxim Group Reiterated Rating Hold
Recent Trading Activity for Biostage, Inc. (NASDAQ:BSTG)
Shares of Biostage, Inc. closed the previous trading session at 0.316 down -0.013 -3.84% with 1,874,116 shares trading hands.